Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Natera, Inc.
University Health Network, Toronto
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Taproot Health
Cedars-Sinai Medical Center
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Imperial College London
SpeciCare
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
ImmunoFrontier, Inc.
New Mexico Cancer Research Alliance